Details about medicine:

This medicine currently does not have an active marketing authorisation.

HULIO®

INN/Active substance:

adalimumab

Pharmaceutical form:

Rastvor za injekciju u napunjenom injekcionom špricu

Strength:

40mg/0.8ml

Packaging:

Ukupno 2 napunjena injekciona šprica sa po 0.8ml rastvora za injekciju u kartonskoj kutiji

ATC:

L04AB04

Manufacturer:

McDermott Laboratories Limited T/A Mylan Dublin Biologics, Newenham Court, Northern Cross, Malahide Road, Dublin 17, Irska
Mylan Germany GmbH, Benzstrasse 1, Bad Homburg, 61352, Njemačka

Marketing authorisation holder:

DRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA

Dispensing mode:

Ograničen recept

Marketing authorisation number:

2030/21/778-187

Authorisation Date:

2021-05-20

Manner of advertising:

Promocija namijenjena stručnoj javnosti

Documentation

Odobreni Sažetak karakteristika lijeka

Download

Odobreno Uputstvo za lijek

Download

Search register

Here you can search for medicines in our register

Sign up for

Newsletter